VTR - Ventas - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92276F1003
Senior Housing, Medical Buildings, Research Centers, Healthcare Facilities
Ventas Inc. (NYSE: VTR) is a prominent real estate investment trust (REIT) listed on the S&P 500, dedicated to generating consistent and sustainable returns for its shareholders by creating exceptional environments that cater to the growing needs of the aging population.
The company's growth strategy is centered around its senior housing communities, which provide a range of valuable services to residents, enabling them to live comfortably and thrive in supportive environments. These communities are designed to promote independence, social interaction, and access to care, ultimately enhancing the overall quality of life for seniors.
Ventas' success is fueled by its unparalleled operational expertise, coupled with data-driven insights from its proprietary Ventas Operational InsightsTM platform. This platform provides actionable intelligence, enabling the company to optimize its portfolio performance, identify opportunities, and make informed decisions. Additionally, Ventas' extensive relationships and strong financial position enable it to drive growth and achieve outsized performance across its diverse portfolio of approximately 1,400 properties.
The Ventas portfolio is diversified across senior housing communities, outpatient medical buildings, research centers, and healthcare facilities, with a presence in both North America and the United Kingdom. This diversified portfolio provides a stable source of income and enables the company to capitalize on emerging trends and opportunities in the healthcare and senior living sectors.
At the heart of Ventas' success is a team of talented professionals who share a common purpose of helping people live longer, healthier, and happier lives. The company's commitment to excellence, integrity, and social responsibility is reflected in its operations, investments, and community engagement initiatives.
For more information about Ventas Inc., please visit https://www.ventasreit.com.
Drawdown (Underwater) Chart
![Drawdown / Underwater Chart for VTR - Ventas - Stock Price & Dividends](https://www.valueray.com/images/drawdown_chart/VTR.NYSE_drawdown.png)
Overall Trend and Yearly Seasonality
![Drawdown / Underwater Chart for VTR - Ventas - Stock Price & Dividends](https://www.valueray.com/images/chart/VTR.NYSE_seasonality.png)
VTR Stock Overview
Market Cap in USD | 21,230m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC SubIndustry | Health Care REITs |
TER | 0.00% |
IPO / Inception | 1998-05-04 |
VTR Stock Ratings
Growth 5y | 5.91 |
Fundamental | -16.5 |
Dividend | 11.4 |
Rel. Performance vs Sector | 0.79 |
Analysts | 4.11/5 |
Fair Price Momentum | 51.65 USD |
Fair Price DCF | 51.61 USD |
VTR Dividends
Dividend Yield 12m | 3.35% |
Yield on Cost 5y | 3.30% |
Dividends CAGR 5y | -10.70% |
Payout Consistency | 96.8% |
VTR Growth Ratios
Growth 12m | 16.09% |
Growth Correlation 12m | 49% |
Growth Correlation 3m | 86% |
CAGR 5y | -0.30% |
CAGR/Mean DD 5y | -0.01 |
Sharpe Ratio 12m | 0.43 |
Alpha vs SP500 12m | -9.29 |
Beta vs SP500 5y weekly | 1.30 |
ValueRay RSI | 74.58 |
Volatility GJR Garch 1y | 14.21% |
Price / SMA 50 | 6.63% |
Price / SMA 200 | 17.46% |
Current Volume | 1370.4k |
Average Volume 20d | 1885.2k |
External Links for VTR Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of July 27, 2024, the stock is trading at USD 53.75 with a total of 1,370,416 shares traded.
Over the past week, the price has changed by +0.84%, over one month by +8.78%, over three months by +23.24% and over the past year by +15.16%.
According to ValueRays Forecast Model, VTR Ventas will be worth about 56.4 in July 2025. The stock is currently trading at 53.75. This means that the stock has a potential upside of +4.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 54 | 0.47 |
Analysts Target Price | 50 | -6.98 |
ValueRay Target Price | 56.4 | 4.84 |